Fair value · Evotec SE (EVO) · updated 2026-10-24 · from 20-F FY2025
Evotec trades at $1.50. We are not reading assumptions out of that price: our price is for one ADS, which represents 0.5 ordinary shares, but this company files its per-share figures per ordinary share — so these methods need a per-share restatement we do not yet publish.
Everything below is unaffected: the filed statements, the filing they came from, and EVO’s growth history are all as reported.
The filing behind these numbers
Evotec SE- Revenue
- EUR 788.4M
- Diluted EPS
- EUR -0.58
- Free cash flow
- EUR -81.7M
- operating cash flow − capital expenditure
- Diluted shares
- 177.6M
- weighted average
20-F FY2025 · fiscal year ended 2025-12-31 · filed 2026-04-08 · accession 0001104659-26-040767
Open this filing on sec.govNeed EVO data in your own agent or pipeline?
The valuation data behind this page — DCF fair value, margin of safety, PE vs industry, analyst estimates — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.